Cytec (UNKNOWN:CYT.DL) results for the company's Q1 have been released. For the quarter, the net sales figure was $477 million, a robust year-over-year increase of 26% from the $378 million in the same period the previous year. Attributable net profit, on the other hand, fell by 37% over that same time frame, to land at $33.5 million ($0.73 per diluted share) from Q1 2012's result of $53.1 million ($1.14).

Cytec also provided updates to its forward guidance. For the entirety of fiscal 2013, adjusted diluted EPS is now expected to come in at $4.50-$4.75. This is a downward revision from the previous anticipation of $4.70-$4.95, although the firm stressed that it is still a "substantial" improvement over 2012's tally of $3.02.

Fool contributor Eric Volkman has no position in Cytec. The Motley Fool has no position in Cytec. Try any of our Foolish newsletter services free for 30 days. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy.